|
|
Volumn 60, Issue 13 Suppl 2, 2003, Pages
|
|
Advances in the understanding and management of dyslipidemia: using niacin-based therapies.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
HIGH DENSITY LIPOPROTEIN CHOLESTEROL;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
LIPOPROTEIN;
NICOTINIC ACID;
TRIACYLGLYCEROL;
CHEMICALLY INDUCED DISORDER;
CHEMISTRY;
CONFERENCE PAPER;
CORONARY ARTERY ATHEROSCLEROSIS;
DELAYED RELEASE FORMULATION;
DRUG COMBINATION;
DRUG POTENTIATION;
HUMAN;
HYPERLIPIDEMIA;
METABOLISM;
PATIENT EDUCATION;
PHARMACOKINETICS;
RHABDOMYOLYSIS;
CHEMISTRY, PHARMACEUTICAL;
CHOLESTEROL, HDL;
CORONARY ARTERIOSCLEROSIS;
DELAYED-ACTION PREPARATIONS;
DRUG COMBINATIONS;
DRUG SYNERGISM;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
HYPERLIPIDEMIAS;
LIPOPROTEINS;
NIACIN;
PATIENT EDUCATION;
RHABDOMYOLYSIS;
THERAPEUTIC EQUIVALENCY;
TRIGLYCERIDES;
MLCS;
MLOWN;
|
|
EID: 0642374925
PISSN: 10792082
EISSN: None
Source Type: Journal
DOI: 10.1093/ajhp/60.suppl_2.s15 Document Type: Conference Paper |
|
Times cited : (8)
|
|
References (0)
|
